Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Clinical trial NCT06881888 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06881888
- Sponsor
- University of Alabama at Birmingham
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2027-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.